About the Authors

Victorine A. Mensah

avictorine@outlook.com

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Aly Gueye

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Magatte Ndiaye

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Nick J. Edwards

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Danny Wright

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Nicholas A. Anagnostou

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Massamba Syll

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Amy Ndaw

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Annie Abiola

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Carly Bliss

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Jules-François Gomis

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Ines Petersen

Affiliation European Vaccine Initiative, Heidelberg, Germany

Caroline Ogwang

Affiliation Kenya Medical Research Institute, Kilifi, Kenya

Tandakha Dieye

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Nicola K. Viebig

Affiliation European Vaccine Initiative, Heidelberg, Germany

Alison M. Lawrie

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Rachel Roberts

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Alfredo Nicosia

Affiliations ReiThera (formerly Okairos), Rome, Italy, CEINGE, via Gaetano Salvatore, Naples, Italy

Babacar Faye

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Oumar Gaye

Affiliation Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal

Odile Leroy

Affiliation European Vaccine Initiative, Heidelberg, Germany

Egeruan B. Imoukhuede

† Deceased.

Affiliations Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom, European Vaccine Initiative, Heidelberg, Germany

Katie J. Ewer

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Philip Bejon

Affiliation Kenya Medical Research Institute, Kilifi, Kenya

Adrian V. S. Hill

Affiliation Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Badara Cisse

Affiliations Parasitology department, Faculty of Medicine University Cheikh Anta Diop, Dakar, Senegal, London School of Hygiene and Tropical Medicine, London United Kingdom

MVVC group

See Acknowledgments for full listing of MVVC investigators

Competing Interests

We have the following interests. Adrian V.S. Hill is a named inventor on patent applications and patents on malaria vectored vaccines and immunisation regimes including the following (WO2008/122769, Adenoviral vector encoding malaria antigen; and WO 2008/122811 Novel adenovirus vectors). Egeruan Imoukhuede and Ines Petersen were employees of EVI at the time of the study, which supports the development and testing of malaria vaccines. Nicola Viebig is an employee of EVI and Odile Leroy is executive director of EVI. Authors from ReiThera (formerly Okairos) are employees of and/or shareholders in ReiThera, which is developing vectored vaccines for malaria and other diseases. Alfredo Nicosia was employed by ReiThera (formerly Okairos) at the time of the study. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceptualization: AVSH NAA EBI BC AML A. Nicosia. Data curation: JFG PB. Formal analysis: PB KJE BC JFG. Funding acquisition: MVVC group A. Nicosia AVSH OL EBI PB BC. Investigation: VAM BC AG MS MN A. Ndaw AA BF DW NJE CB CO PB. Methodology: NAA VAM AG BC PB. Project administration: VAM RR NKV IP. Resources: A. Nicosia KJE VAM. Supervision: BC EBI AVSH OL OG NKV TD AML. Validation: VAM AVSH BC KJE. Visualization: VAM KJE BC PB. Writing – original draft: VAM BC AVSH KJE PB NJE. Writing – review & editing: VAM BC AVSH KJE PB NJE NKV BF MN.